Department of Infectious Disease and Global Health
DVM - University of Minnesota College of Veterinary Medicine - 1996
PhD - Albert Einstein College of Medicine - 1992
MS - Albert Einstein College of Medicine - 1991
BA - Hamline University - 1989
Diplomate of the American College of Veterinary Microbiologists (DACVM)
Karen Baldwin, Animal Specialist
Courtney Boucher, Research Technician
Kwasi Ofori, Research Assistant
General Research Interest
Development of immune-based methods for diagnosis, therapy, and prevention of infectious and toxin-mediated diseases of human, veterinary and/or zoonotic concern; animal model development; in vivo evaluation of candidate therapeutics; veterinary microbiology and parasitology.
Research and Clinical Interests
- Passive Immunotherapy
- Microbial Pathogenesis
- Animal Model Development
- Evaluation of Candidate Therapeutics
- Conjugate Vaccines
- One Health
- Mukherjee, J., C. McCann, K. Baldwin, K. Ofori, C. Taylor, J. Hill, C. Shoemaker, P. Harrison and S. Tzipori. 2012. “Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1.” Toxins 4(12):1565-1581.
Mukherjee, J., J.M. Tremblay, C.E. Leysath, K. Ofori, K. Baldwin, X. Feng, D. Bedenice, S. Tzipori, and C.B. Shoemaker. 2011. A Novel Strategy for Development or Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model.” Plos One 7:1-7e29941.
Sepulveda, J., J. Mukherjee, S. Tzipori, L. Simpson, C. Shoemaker. 2010. “Efficient serum clearance of botulinum neurotoxin using a pool of small antitoxin binding agents." Infection and Immunity 78(2):756-763.
Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O’Donnell, S. Rich, A. Donohue-Rolfe, and S. Tzipori. 2002. “Production and Characterization of Protective Human Antibodies Against Shiga-Toxin 1 (Stx1).” Infection and Immunity 70(10):5896-5899.
Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O’Donnell, S. Rich, A. Donohue-Rolfe, and S. Tzipori. 2002. “Human Stx2 Antibodies Prevent Systemic Complications of Escherichia coli 0157:H7 Infection.” Infection and Immunity 70(2):612-619.
Mukherjee, J., M.D. Scharff, and A. Casadevall. 1995. "Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Enhance Fluconazole Efficacy." Antimicrobial Agents and Chemotherapy 39:1398-1405.
Mukherjee, J., M.D. Scharff, and A. Casadevall. 1995. "Variable Efficacy of Passive Antibody Administration Against Diverse Cryptococcus neoformans Strains." Infection and Immunity 63:3353-3359.
Mukherjee, J., G. Nussbaum, M.D. Scharff, and A. Casadevall. 1995. "Somatic Mutation Can Generate Differences in Specificity that Change the Protective Efficacy of Antibodies to Cryptococcus neoformans." Journal of Experimental Medicine 181:405-409.
Mukherjee, J., L.S. Zuckier, M.D. Scharff, and A. Casadevall. 1994. "Therapeutic Efficacy of Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Alone and in Combination with Amphotericin B." Antimicrobial Agents and Chemotherapy 38:580-587.
Mukherjee, J., L.-A. Pirofski, M.D. Scharff, and A. Casadevall. 1993. "Antibody-Mediated Protection in Mice with Lethal Intracerebral Cryptococcus neoformans Infection." Proceedings of the National Academy of Science (PNAS) 90:3636-3640.
Mukherjee, J., A. Casadevall, and M.D. Scharff. 1993. "Molecular Characterization of the Humoral Responses to Cryptococcus neoformans Infection and Glucuronoxylomannan-Tetanus Toxoid Conjugate Immunization." Journal of Experimental Medicine 177:1105-1116.
Back to the Top